Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KIB-PIA02 H5N1 influenza vaccine in healthy Japanese adults
jRCT1090220007Phase 3Completed
- Sponsor
- National Hospital Organization Mie National Hospital
- Start
- Aug 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of KIB-PIA H5N1 influenza vaccine in influenza (2 arms), sponsored by National Hospital Organization Mie National Hospital. Primary endpoints: Hemagglutination inhibition (HI) antibody titer against H5 antigen, Neutralizing antibody titer against H5N1 influenza virus and 1 more. Started Aug 2006; status: completed.
02
Drugs
KIB-PIA H5N1 influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT1090220007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220007.